The purpose of Pfizer's Medical Affairs team is to partner with healthcare providers, patient advocacy groups, and other stakeholders to address population and patient needs. They draw on their extensive knowledge and experience across medical science to generate evidence, lead advisory boards, and respond to unsolicited requests from healthcare professionals. By engaging in high-quality scientific exchanges, the team aims to deepen the understanding of Pfizer's innovative therapies and facilitate access to treatments.
 

"At Pfizer, our Medical Affairs team is driven by a deep commitment to advancing scientific knowledge and improving patient care," said Vratislav Hadrava, head of Medical Affairs in Canada. "By collaborating closely with healthcare professionals, we are working to ensure that patients have access to the right medicines at the right time."
 

Pfizer's legacy of medical innovation stretches back over 175 years. From developing smallpox vaccines in 1915 to bringing COVID-19 vaccines to the world, the company has remained steadfast in its commitment to profoundly impact patient health. This proud history inspires the Medical Affairs team as they look to the future.
 

As Pfizer expands its offerings and capabilities, the Medical Affairs team is discovering new and innovative ways to connect with healthcare professionals. Through enhanced digital tools and omnichannel communications, they are working to ensure that providers have the data they need, when they need it, to make informed decisions for their patients.
 

Anchored in Pfizer's legacy of scientific excellence and ethical transparency, the Medical Affairs team is proud to be a trusted partner in shaping the future of healthcare. By collaborating with healthcare professionals and putting patients at the center of everything they do, the team is helping to advance scientific knowledge and improve patient care across Canada.
 

Discover the impactful work of Pfizer Medical Affairs in the video below.